The latest EBIT for 9546.SR is $58M as of June 2026. That compares with $82M in the prior-year period — down 29.3% year over year. That is above the sector sector average of $-25M. Investors often review this figure alongside Naba Alsaha Medical Services Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, 9546.SR's EBIT moved from $82M to $58M — a 29.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Naba Alsaha Medical Services Company's operating scale or balance-sheet position.

Against its sector companies, 9546.SR currently prints $58M for EBIT, while the sector average sits near $-25M. That is roughly 329.6% above the sector mean. Large gaps often invite a closer look at Naba Alsaha Medical Services Company's growth, margins, and balance sheet.

A EBIT figure of $58M for 9546.SR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-25M. Explore the charts below for those layers of context.

After noting 9546.SR's EBIT ($58M), review year-over-year change from $82M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.